Trial · NCT00931723
Results by group42
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 42
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in the Young Mania Rating Scale (YMRS) Total Score From Baseline to Final Assessment (Day 43) | Lithium+Quetiapine XR | -22.8 | Standard Error 0.706 | Scores on a scale | |
| Change in the Young Mania Rating Scale (YMRS) Total Score From Baseline to Final Assessment (Day 43) | Placebo+Quetiapine XR | -20.1 | Standard Error 0.711 | Scores on a scale | |
| The Number of Patients With Clinically Significant Response. | Lithium+Quetiapine XR | 137 | Participants | ||
| The Number of Patients With Clinically Significant Response. | Placebo+Quetiapine XR | 120 | Participants | ||
| Remission | Lithium+Quetiapine XR | 125 | Participants | ||
| Remission | Placebo+Quetiapine XR | 105 | Participants | ||
| Change From Baseline to Day 43 in CGI-BP-S (Clinical Global Impressions for Bipolar Disorder-Severity of Illness) | Lithium+Quetiapine XR | -2.5 | Standard Error 0.079 | Scores on a scale | |
| Change From Baseline to Day 43 in CGI-BP-S (Clinical Global Impressions for Bipolar Disorder-Severity of Illness) | Placebo+Quetiapine XR | -2.2 | Standard Error 0.080 | Scores on a scale | |
| Change From Baseline to Day 43 in CGI-BP-C (Clinical Global Impressions for Bipolar Disorder-Change From Preceding Phase) | Lithium+Quetiapine XR | 1.7 | Standard Error 0.085 | Scores on a scale | |
| Change From Baseline to Day 43 in CGI-BP-C (Clinical Global Impressions for Bipolar Disorder-Change From Preceding Phase) | Placebo+Quetiapine XR | 1.9 | Standard Error 0.086 | Scores on a scale | |
| Improvement of Overall Bipolar Illness | Lithium+Quetiapine XR | 134 | Participants | ||
| Improvement of Overall Bipolar Illness | Placebo+Quetiapine XR | 125 | Participants | ||
| Change From Baseline to Day 43 in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score | Lithium+Quetiapine XR | -4.8 | Standard Error 0.366 | Scores on a scale | |
| Change From Baseline to Day 43 in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score | Placebo+Quetiapine XR | -4.1 | Standard Error 0.368 | Scores on a scale | |
| Change From Baseline to Day 43 in Positive and Negative Syndrome Scale (PANSS) Total Score | Lithium+Quetiapine XR | -19.2 | Standard Error 0.914 | Scores on a scale | |
| Change From Baseline to Day 43 in Positive and Negative Syndrome Scale (PANSS) Total Score | Placebo+Quetiapine XR | -15.6 | Standard Error 0.914 | Scores on a scale | |
| Change From Baseline to Day 43 in PANSS Activation Subscale Score | Lithium+Quetiapine XR | -7.1 | Standard Error 0.281 | Scores on a scale | |
| Change From Baseline to Day 43 in PANSS Activation Subscale Score | Placebo+Quetiapine XR | -5.9 | Standard Error 0.283 | Scores on a scale | |
| Change From Baseline to Day 43 in PANSS Positive Subscale Score | Lithium+Quetiapine XR | -8.1 | Standard Error 0.316 | Scores on a scale | |
| Change From Baseline to Day 43 in PANSS Positive Subscale Score | Placebo+Quetiapine XR | -7.0 | Standard Error 0.316 | Scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00931723/results